BACKGROUND: Major depression and depressive symptoms are associated with cardiovascular disease (CVD), but the impact of depression on early atherogenesis is less well known, particularly in women and minorities. This study examined whether depressive symptoms are associated with progression of coronary artery calcification (CAC) among women at midlife. METHODS: The SWAN is a longitudinal, multisite study assessing health and psychologic factors in midlife women. An ancillary study (SWAN Heart) evaluated subclinical atherosclerosis in women who reported no history of CVD or diabetes. In 346 women, CAC was measured twice by electron beam computed tomography, an average of 2.3 years apart. Progression, defined as an increase by ≥10 Agatston units, was analyzed using relative risk (RR) regression. Depressive symptoms were assessed with the Center for Epidemiologic Studies Depression (CES-D) Scale. RESULTS: Progression of CAC was observed in 67 women (19.1%). Each 1-SD-higher CES-D score at baseline related to a 25% increased risk of CAC progression (RR 1.25, 95% CI 1.06-1.47, P = .007), adjusting for age, time between scans, ethnicity, education, menopausal status, and known CVD risk factors. This risk was similar to the risk induced by body mass index (RR 1.31, 95% CI 1.11-1.54, P = .001) and systolic blood pressure (RR 1.28, 95% CI 1.06-1.55, P = .01). CONCLUSIONS: Depressive symptoms were independently associated with progression of CAC in this cohort of midlife women. Depressive symptoms may represent a risk factor that is potentially modifiable for early prevention of CVD in women.
BACKGROUND: Major depression and depressive symptoms are associated with cardiovascular disease (CVD), but the impact of depression on early atherogenesis is less well known, particularly in women and minorities. This study examined whether depressive symptoms are associated with progression of coronary artery calcification (CAC) among women at midlife. METHODS: The SWAN is a longitudinal, multisite study assessing health and psychologic factors in midlife women. An ancillary study (SWAN Heart) evaluated subclinical atherosclerosis in women who reported no history of CVD or diabetes. In 346 women, CAC was measured twice by electron beam computed tomography, an average of 2.3 years apart. Progression, defined as an increase by ≥10 Agatston units, was analyzed using relative risk (RR) regression. Depressive symptoms were assessed with the Center for Epidemiologic Studies Depression (CES-D) Scale. RESULTS: Progression of CAC was observed in 67 women (19.1%). Each 1-SD-higher CES-D score at baseline related to a 25% increased risk of CAC progression (RR 1.25, 95% CI 1.06-1.47, P = .007), adjusting for age, time between scans, ethnicity, education, menopausal status, and known CVD risk factors. This risk was similar to the risk induced by body mass index (RR 1.31, 95% CI 1.11-1.54, P = .001) and systolic blood pressure (RR 1.28, 95% CI 1.06-1.55, P = .01). CONCLUSIONS:Depressive symptoms were independently associated with progression of CAC in this cohort of midlife women. Depressive symptoms may represent a risk factor that is potentially modifiable for early prevention of CVD in women.
Authors: Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Robert J Adams; Jarett D Berry; Todd M Brown; Mercedes R Carnethon; Shifan Dai; Giovanni de Simone; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Kurt J Greenlund; Susan M Hailpern; John A Heit; P Michael Ho; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Mary M McDermott; James B Meigs; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Wayne D Rosamond; Paul D Sorlie; Randall S Stafford; Tanya N Turan; Melanie B Turner; Nathan D Wong; Judith Wylie-Rosett Journal: Circulation Date: 2010-12-15 Impact factor: 29.690
Authors: Tulika Jain; Ronald Peshock; Darren K McGuire; DuWayne Willett; Zhoaxia Yu; Zhoazia Yu; Gloria L Vega; Rudy Guerra; Helen H Hobbs; Scott M Grundy Journal: J Am Coll Cardiol Date: 2004-09-01 Impact factor: 24.094
Authors: George T Kondos; Julie Anne Hoff; Alexander Sevrukov; Martha L Daviglus; Daniel B Garside; Stephen S Devries; Eva V Chomka; Kiang Liu Journal: Circulation Date: 2003-05-12 Impact factor: 29.690
Authors: Nathan D Wong; Maria G Sciammarella; Donna Polk; Amy Gallagher; Lisa Miranda-Peats; Brian Whitcomb; Rory Hachamovitch; John D Friedman; Sean Hayes; Daniel S Berman Journal: J Am Coll Cardiol Date: 2003-05-07 Impact factor: 24.094
Authors: Henning Tiemeier; Wim van Dijck; Albert Hofman; Jacqueline C M Witteman; Theo Stijnen; Monique M B Breteler Journal: Arch Gen Psychiatry Date: 2004-04
Authors: Jesse C Stewart; Desiree J Zielke; Misty A W Hawkins; David R Williams; Mercedes R Carnethon; Sarah S Knox; Karen A Matthews Journal: Circulation Date: 2012-06-18 Impact factor: 29.690
Authors: Imke Janssen; Lynda H Powell; Mateusz S Jasielec; Karen A Matthews; Steven M Hollenberg; Kim Sutton-Tyrrell; Susan A Everson-Rose Journal: Ann Behav Med Date: 2012-02
Authors: Rosalba Hernandez; Norrina Bai Allen; Kiang Liu; Jeremiah Stamler; Kathryn Jean Reid; Phyllis C Zee; Donghong Wu; Joseph Kang; Daniel B Garside; Martha L Daviglus Journal: Prev Med Date: 2014-01-13 Impact factor: 4.018
Authors: L Raz; L V Hunter; N M Dowling; W Wharton; C E Gleason; M Jayachandran; L Anderson; S Asthana; V M Miller Journal: Climacteric Date: 2015-12-10 Impact factor: 3.005
Authors: Imke Janssen; Lynda H Powell; Karen A Matthews; Mateusz S Jasielec; Steven M Hollenberg; Joyce T Bromberger; Kim Sutton-Tyrrell; Susan A Everson-Rose Journal: Am J Cardiol Date: 2016-04-05 Impact factor: 2.778
Authors: John Bellettiere; Donna Kritz-Silverstein; Gail A Laughlin; Andrea Z LaCroix; Linda K McEvoy; Elizabeth Barrett-Connor Journal: Am J Cardiol Date: 2015-11-18 Impact factor: 2.778